The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
ten years ago we were paul talley and i were invited to work with a group in the netherlands that was going to be a big multi-center alzheimer's prevention trial using sulforaphane 10 years ago 2011. um it was a multi-million dollar trial funding never had i don't know funding started and stopped but it never actually happened
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.